Spike protein from infection (and thus ALSO vaccine induced) can cause damage to cardiac pericytes, to endothelial function, to mitochondria, and can also impair DNA self-repair
by Paul Alexander
Exploding excess (all-cause) mortality & plunging birth rates can be explained by the ravages of the spike protein; as COVID infection deaths have dropped appreciably, there is a rise in vaccine death
I share 4 pieces of evidence for your perusal and updating of your libraries, the issue being that we know the lethal role of the spike protein itself on cardiac cells, on the vascular walls etc. and we thus must infer that the spike manufactured by your cells induced by the COVID injection, will do same. We also know that spike persists in the body for many months and I argue there is no ‘off’ switch and that it persists life-long, doing damage; Patterson et al. showed us this, indicating that the spike post vaccine will persist as a pathogen and cause life-long damage; no one in their right mind would have chosen the spike ‘mutable’ protein as the antigen target and thus it begs the question, why would Pfizer and Moderna et al. chose the lethal toxic portion of the COVID virus as the component to be made by your cells as the antibody target? We even have evidence that the spike purified, on it’s own, is lethal, it does not need the rest of the viral ball to go along with it:
The capacity of SARS-CoV-2 to infect vascular cells is still debated. Additionally, the SARS-CoV-2 Spike (S) protein may act as a ligand to induce non-infective cellular stress. We tested this hypothesis in pericytes (PCs), which are reportedly reduced in the heart of patients with severe coronavirus disease-2019 (COVID-19). Here we newly show that the in vitro exposure of primary human cardiac PCs to the SARS-CoV-2 wildtype strain or the α and δ variants caused rare infection events. Exposure to the recombinant S protein alone elicited signalling and functional alterations, including: (1) increased migration, (2) reduced ability to support endothelial cell (EC) network formation on Matrigel, (3) secretion of pro-inflammatory molecules typically involved in the cytokine storm, and (4) production of pro-apoptotic factors causing EC death…In conclusion, our findings suggest that the S protein may prompt PC dysfunction, potentially contributing to microvascular injury. This mechanism may have clinical and therapeutic implications.’
SARS-CoV-2 Spike Protein Impairs Endothelial Function via Downregulation of ACE 2
‘in the current study, we show that S protein alone can damage vascular endothelial cells (ECs) by downregulating ACE2 and consequently inhibiting mitochondrial function. We administered a pseudovirus expressing S protein (Pseu-Spike) to Syrian hamsters intratracheally. Lung damage was apparent in animals receiving Pseu-Spike, revealed by thickening of the alveolar septa and increased infiltration of mononuclear cells.’
‘Mounting evidence accumulates that hematopoietic stem/progenitor cells (HSPCs) and endothelial progenitor cells (EPCs) are damaged during severe SARS-Cov-2/COVID-19 infection [1, 2]. It has been reported that patient infected with COVID-19 are frequently presented with anemia, lymphopenia, and thrombocytopenia [1,2,3]. This negative effect of the virus on human hematopoiesis and endothelium has been reported in infected patients and demonstrated in vitro after exposure of cells to SARS-Cov-2/COVID-19 spike protein (SP).’
SARS–CoV–2 Spike Impairs DNA Damage Repair and Inhibits V(D)J Recombination In Vitro
‘Clinical studies have indicated that patients with severe COVID–19 exhibit delayed and weak adaptive immune responses; however, the mechanism by which SARS–CoV–2 impedes adaptive immunity remains unclear. Here, by using an in vitro cell line, we report that the SARS–CoV–2 spike protein significantly inhibits DNA damage repair, which is required for effective V(D)J recombination in adaptive immunity…findings reveal a potential molecular mechanism by which the spike protein might impede adaptive immunity and underscore the potential side effects of full-length spike-based vaccines.’
‘We analyzed T-cell, B-cell, and monocytic subsets in both severe COVID-19 patients and in patients with post-acute sequelae of COVID-19 (PASC). The levels of both intermediate (CD14+, CD16+) and non-classical monocyte (CD14Lo, CD16+) were significantly elevated in PASC patients up to 15 months post-acute infection compared to healthy controls (P=0.002 and P=0.01, respectively). A statistically significant number of non-classical monocytes contained SARS-CoV-2 S1 protein in both severe (P=0.004) and PASC patients (P=0.02) out to 15 months post-infection.’